Pharmacogenomics and Personalized Medicine in Type 2 Diabetes Mellitus: Potential Implications for Clinical Practice
Poongothai Venkatachalapathy,1 Sruthi Padhilahouse,1 Mohan Sellappan,1 Tharunika Subramanian,2 Shilia Jacob Kurian,3 Sonal Sekhar Miraj,3 Mahadev Rao,3 Ashwin Ashok Raut,4 Rupinder Kaur Kanwar,4 Jitendra Singh,4 Sagar Khadanga,5 Sukumar Mondithoka,5 Murali Munisamy4 1Department of Pharmacy Practice,...
Guardado en:
Autores principales: | Venkatachalapathy P, Padhilahouse S, Sellappan M, Subramanian T, Kurian SJ, Miraj SS, Rao M, Raut AA, Kanwar RK, Singh J, Khadanga S, Mondithoka S, Munisamy M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5053c2f23b274392ac1de3c5ab3daa10 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The pharmacogenomics journal
Publicado: (2001) -
Clinical applications of pharmacogenomics
por: Quiñones,Luis, et al.
Publicado: (2017) -
Pharmacogenomics and Rheumatological Practice
por: Chuanhui Xu, et al.
Publicado: (2021) -
Pharmacogenomic Testing and Patient Perception Inform Pain Pharmacotherapy
por: Feng-Hua Loh, et al.
Publicado: (2021) -
American journal of pharmacogenomics genomics-related research in drug development and clinical practice.
Publicado: (2001)